Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.
- Status
- WITHDRAWN
- Phase
- PHASE2
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
- Status
- TERMINATED
- Phase
- PHASE4
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
- Status
- COMPLETED
- Phase
- PHASE4
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation
- Status
- UNKNOWN
- Phase
- PHASE4
Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation
- Status
- COMPLETED
- Phase
- NA
Diabetogenicity of Cyclosporine and Tacrolimus
- Status
- COMPLETED
- Phase
- PHASE4